Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment

被引:232
作者
Minatoguchi, S
Takemura, G
Chen, XH
Wang, NY
Uno, Y
Koda, M
Arai, M
Misao, Y
Lu, CJ
Suzuki, K
Goto, K
Komada, A
Takahashi, T
Kosai, K
Fujiwara, T
Fujiwara, H
机构
[1] Gifu Univ, Sch Med, Dept Internal Med 2, Gifu 5008705, Japan
[2] Gifu Univ, Sch Med, Dept Cardiovasc Regenerat, Gifu, Japan
[3] Kyoto Womens Univ, Kyoto, Japan
关键词
myocytes; ischemia; reperfusion; matrix metalloproteinase;
D O I
10.1161/01.CIR.0000129770.93985.3E
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - We investigated whether the improvement of cardiac function and remodeling after myocardial infarction (MI) by granulocyte colony - stimulating factor (G-CSF) relates to acceleration of the healing process, in addition to myocardial regeneration. Methods and Results - In a 30-minute coronary occlusion and reperfusion rabbit model, saline (S) or 10 mug . kg(-1) . d(-1) of human recombinant G-CSF ( G) was injected subcutaneously from 1 to 5 days after MI. Smaller left ventricular (LV) dimension, increased LV ejection fraction, and thicker infarct-LV wall were seen in G at 3 months after MI. At 2, 7, and 14 days and 3 months after MI, necrotic tissue areas were 14.2 +/- 1.5/13.4 +/- 1.1, 0.4 +/- 0.1/1.8 +/- 0.5*, 0/0, and 0/0 mm(2) . slice(-1) . kg(-1), granulation areas 0/ 0, 4.0 +/- 0.7/ 8.5 +/- 1.0*, 3.9 +/- 0.8/5.7 +/- 0.7,* and 0/0 mm(2) . slice(-1) . kg(-1), and scar areas 0/ 0, 0/ 0, 0/0, and 4.2 +/- 0.5/ 7.9 +/- 0.9* mm(2) . slice(-1) . kg(-1) in G and S, respectively (* P < 0.05, G versus S). Clear increases of macrophages and of matrix metalloproteinases (MMP) 1 and 9 were seen in G at 7 days after MI. This suggests that G accelerates absorption of necrotic tissues via increase of macrophages and reduces granulation and scar tissues via expression of MMPs. Meanwhile, surviving myocardial tissue areas within the risk areas were significantly increased in G despite there being no difference in LV weight, LV wall area, or cardiomyocyte size between G and S. Confocal microscopy revealed significant increases of cardiomyocytes with positive 3,3,3', 3'-tetramethylindocarbocyanine perchlorate and positive troponin I in G, suggesting enhanced myocardial regeneration by G. Conclusions - The acceleration of the healing process and myocardial regeneration may play an important role for the beneficial effect of post-MI G-CSF treatment.
引用
收藏
页码:2572 / 2580
页数:9
相关论文
共 20 条
  • [1] Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
    Alvarez-Dolado, M
    Pardal, R
    Garcia-Vardugo, JM
    Fike, JR
    Lee, HO
    Pfeffer, K
    Lois, C
    Morrison, SJ
    Alvarez-Buylla, A
    [J]. NATURE, 2003, 425 (6961) : 968 - 973
  • [2] Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization
    Asahara, T
    Masuda, H
    Takahashi, T
    Kalka, C
    Pastore, C
    Silver, M
    Kearne, M
    Magner, M
    Isner, JM
    [J]. CIRCULATION RESEARCH, 1999, 85 (03) : 221 - 228
  • [3] Matrix metalloproteinase-9 (gelatinase B) is elevated during mobilization of peripheral blood progenitor cells by G-CSF
    Carstanjen, D
    Ulbricht, N
    Iacone, A
    Regenfus, M
    Salama, A
    [J]. TRANSFUSION, 2002, 42 (05) : 588 - 596
  • [4] Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
    Creemers, EEJM
    Cleutjens, JPM
    Smits, JFM
    Daemen, MJAP
    [J]. CIRCULATION RESEARCH, 2001, 89 (03) : 201 - 210
  • [5] Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
    Ducharme, A
    Frantz, S
    Aikawa, M
    Rabkin, E
    Lindsey, M
    Rohde, LE
    Schoen, FJ
    Kelly, RA
    Werb, Z
    Libby, P
    Lee, RT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) : 55 - 62
  • [6] Randomised placebo-controlled trial of granulocyte-colony stimulating factor in diabetic foot infection
    Gough, A
    Clapperton, M
    Rolando, N
    Foster, AVM
    PhilpottHoward, J
    Edmonds, ME
    [J]. LANCET, 1997, 350 (9081) : 855 - 859
  • [7] Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    Heymans, S
    Luttun, A
    Nuyens, D
    Theilmeier, G
    Creemers, E
    Moons, L
    Dyspersin, GD
    Cleutjens, JPM
    Shipley, M
    Angellilo, A
    Levi, M
    Nübe, O
    Baker, A
    Keshet, E
    Lupu, F
    Herbert, JM
    Smits, JFM
    Shapiro, SD
    Baes, M
    Borgers, M
    Collen, D
    Daemen, MJAP
    Carmeliet, P
    [J]. NATURE MEDICINE, 1999, 5 (10) : 1135 - 1142
  • [8] Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization
    Kalka, C
    Masuda, H
    Takahashi, T
    Kalka-Moll, WM
    Silver, M
    Kearney, M
    Li, T
    Isner, JM
    Asahara, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3422 - 3427
  • [9] A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation
    Kröger, N
    Renges, H
    Krüger, W
    Gutensohn, K
    Löliger, C
    Carrero, I
    Cortes, L
    Zander, AR
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (03) : 761 - 765
  • [10] A novel anti-diabetic drug, miglitol, markedly reduces myocardial infarct size in rabbits
    Minatoguchi, S
    Arai, M
    Uno, Y
    Kariya, T
    Nishida, Y
    Hashimoto, K
    Kawasaki, M
    Takemura, G
    Fujiwara, T
    Fujiwara, H
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (08) : 1667 - 1672